Senores Pharmaceuticals Limited — Others, 25-06-2025: Trading Window

Senores Pharmaceuticals Limited has announced a trading window closure for its Directors, Promoters, Designated Persons, and their immediate relatives starting July 1, 2025, until 48 hours after the announcement of the financial results for the quarter ending June 30, 2025. This measure restricts trading in the company's securities during this period to prevent insider trading. The date for the board meeting to approve these financial results will be shared later. This move helps maintain fair market practices and protects shareholder interests.